Use of tumor necrosis factor α inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action-Reference-Cited by-同舟云学术

Use of tumor necrosis factor α inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action

Published:2010-06-16 Issue:9 Volume:29 Page:1021-1029
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Carroll Matthew B.,Forgione Michael A.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-010-1523-2.pdf

Reference86 articles.

1. Giles JT, Bathon JM (2004) Serious infections associated with anticytokine therapies in the rheumatic diseases. J Intensive Care Med 19:320–334

2. Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 345:1098–1103

3. Dienstag JL (2008) Hepatitis B virus infection. N Engl J Med 359(14):1486–1500

4. Shale MJ, Seow CH, Coffin CS et al (2009) Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease. Aliment Pharmacol Ther 31:20–34

5. U.S. Food and Drug Administration Center for Drug Evaluation and Research (2008) Drugs@FDA: Adalimumab Label Information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125057s114lbl.pdf . Accessed 8 August 2009

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of Guideline-Based HBV Reactivation Management in Patients with Chronic HBV Infections of HBsAg or Resolved HBV Infection Undergoing Immunosuppressive Therapy;Infectious Diseases and Therapy;2024-05-29

2. Role of Hepatitis B Surface Antibodies in Risk for Hepatitis B Virus Reactivation During Anti–Tumor Necrosis Factor Therapy;Clinical Gastroenterology and Hepatology;2023-04

3. Infections Related to Biologic Response Modifying Drug Therapy;Principles and Practice of Pediatric Infectious Diseases;2023

4. Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection;Clinical Drug Investigation;2022-05-28

5. Biyolojik DMARD Kullanan Hastalarda Kronik Hepatit B Enfeksiyonu ve Okkült Hepatit B Sıklığı ve Tedavi Yönetimi;Medical Journal of Western Black Sea;2022-04-28